PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34638904-2	2021	Interleukin-33 (IL-33)/suppression of tumorigenicity 2 (ST2) axis is known to drive TH2 response, while its effect on GAS infection is unclear.	th2	84-87	interleukin 33	Mus musculus	16-21	
32977238-9	2020	CONCLUSIONS: CS induces IL-33 expression in intestinal epithelial cells to promote Th2 polarization in the intestinal tissues and facilitates FA development.	th2	83-86	interleukin 33	Mus musculus	24-29	
34324507-3	2021	Studies have indicated that Th2 response is the main immune defense mechanism against toxocariasis, however, there are still few studies related to this response, mainly the IL-33/ST2 pathway.	th2	28-31	interleukin 33	Mus musculus	174-179	
34324507-5	2021	By binding to its ST2 receptor, IL-33 stimulating the Th2 polarized immune cell and cytokine responses.	th2	54-57	interleukin 33	Mus musculus	32-37	
34324507-9	2021	Collectively, our results demonstrate that the Th2 immune response triggered by IL-33/ST2 pathway mediates susceptibility to T. canis, related to parasitic burden, eosinophilia and granuloma formation in which consequently contributes to tissue inflammation and injury.	th2	47-50	interleukin 33	Mus musculus	80-85	
34460865-10	2021	By stimulating the release of IL-33, alum induced Th2 immunity via IL-5 and IL-13 production in group 2 innate lymphoid cells (ILC2s) and increased MHC class II expression in antigen-presenting cells (APCs) in the lung.	th2	50-53	interleukin 33	Mus musculus	30-35	
33010253-1	2021	BACKGROUND & AIMS: IL-33/IL-1F11 is an important mediator for the development of Th2-driven inflammatory disorders and has also been implicated in the pathogenesis of GI-related cancers, including gastric carcinoma.	th2	81-84	interleukin 33	Mus musculus	19-24	
33010253-1	2021	BACKGROUND & AIMS: IL-33/IL-1F11 is an important mediator for the development of Th2-driven inflammatory disorders and has also been implicated in the pathogenesis of GI-related cancers, including gastric carcinoma.	th2	81-84	interleukin 33	Mus musculus	25-32	
32563138-5	2020	IL-33 is an alarmin which increases innate immunity through Th2 responses.	th2	60-63	interleukin 33	Mus musculus	0-5	
32240120-0	2020	Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses.	th2	81-84	interleukin 33	Mus musculus	66-71	
32292403-2	2020	In addition, IL-33 has also been shown to work as a positive regulator that initiates and maintains a Th2 immune response.	th2	102-105	interleukin 33	Mus musculus	13-18	
30642984-1	2019	The cytokine IL-33 is a well-established inducer of Th2 responses.	th2	52-55	interleukin 33	Mus musculus	13-18